TOG Review (RCOG Journal)

MRCOG Part 2

Gynaecological Oncology

The fallopian tube as the origin of non-uterine pelvic high-grade serous carcinoma

Key Statistics

  • 0.3% — Of female genital tract cancers = tubal
  • 80% — ↓ Ovarian/tubal/peritoneal cancer risk, RRSO
  • 48–61% — STIC found in sporadic HGPSC

Don't-miss facts

  1. STIC found in 48–61% of sporadic HGPSC; in 10–15% of RRSO specimens – supports primary tubal origin

  2. SEE-FIM protocol: fix 4h; distal 2 cm fimbriae ×4 longitudinal sections; remainder at 2–3 mm; entire tube submitted

  3. RRSO in BRCA1/2: 80% ↓ ovarian/tubal/peritoneal cancer, 77% ↓ all-cause mortality, 50% ↓ breast cancer

  4. 40% of HGPSC have NO associated STIC – tubal origin does not explain all cases

  5. Isolated STIC (Wethington, n=593): 2% incidence; 1/7 staged had +ve washings; no recurrences at median 28 months – management controversial

  6. Salpingectomy: 29% ↓ all epithelial ovarian cancer risk (sterilisation); >60% ↓ serous/peritoneal carcinoma (Lessard- Anderson); adds only 10–16 min to surgery, no ↑ complications

  7. Kwon Markov model: BSO best life expectancy/cost; salpingectomy + delayed oophorectomy best quality-adjusted life expectancy in BRCA carriers

  8. p53 signatures present in ~1/3 of women regardless of BRCA status – not sufficient alone to indicate malignant risk

Lesion spectrum (order of progression)

SCOUT (no p53) p53 signature (≥12 nuclei, benign) STIC (atypia, MIB1>40%) Invasive HGPSC

Abbreviation Key

  • HGPSC — high-grade pelvic serous carcinoma
  • OSE — ovarian surface epithelium (tubal/ovarian/peritoneal)
  • CIC — cortical inclusion cyst
  • STIC — serous tubal intraepithelial carcinoma
  • EUME — extrauterine müllerian epithelium
  • SCOUT — secretory cell outgrowth
  • TIC — tubal intraepithelial carcinoma
  • SEE-FIM — Sectioning and Extensively Examining the FIMbriated
  • FTE — fallopian tube epithelium end of the fallopian tube
  • FIGO — International Federation of Gynecology and Obstetrics
  • RRSO — risk-reducing (bilateral) salpingo-oophorectomy
  • hTERT — human telomerase reverse transcriptase

Source: Aggarwal IM, Lim YH, Lim TYK. The fallopian tube as the origin of non-uterine pelvic high-grade serous carcinoma. The Obstetrician & Gynaecologist 2016;18:143–152. doi:10.1111/tog.12258

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free